AXL and immune system disorder: In oncology, AXL overexpressionis linked to poor prognosis, metastasis, and resistance to conventionaltreatments.−, ,  Consequently, AXL is considered a promising therapeutic target,with both small-molecule inhibitors−,  and monoclonal antibodies under development aimed at blocking its function.AXL is additionally implicated in fibrotic diseases and immune disorders,and it could function in internalization of viral particles, includingSARS-CoV-2, broadening the scope of itstherapeutic and diagnostic potential.